A ‘living GLP-1 drug’ could revolutionize diabetes treatment
Bacteria engineered to sense and reduce glucose levels could be the future of type 2 diabetes treatments, following pre-clinical trials on animal models.
Popular GLP-1 Weight-Loss Drugs Linked to 30% Lower Breast Cancer Risk
New research suggests GLP-1 medications may be associated with a lower likelihood of developing breast cancer.
Ozempic Is Finally Turning the Tide Against Obesity, New Data Shows
As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped. (Lire plus...)